NASDAQ:ADGM Adagio Medical (ADGM) Stock Price, News & Analysis $0.14 0.00 (-2.20%) Closing price 04:00 PM EasternExtended Trading$0.14 +0.00 (+2.17%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsInsider TradesNews and TrendsOwnershipSEC Filings About Adagio Medical Stock (NASDAQ:ADGM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Adagio Medical alerts:Sign Up Key Stats Today's Range$0.13▼$0.1550-Day Range$0.14▼$0.8052-Week Range$0.12▼$2.58Volume1.55 million shsAverage Volume3.13 million shsMarket Capitalization$3.06 millionP/E RatioN/ADividend YieldN/APrice Target$3.50Consensus RatingHold Company Overview Adagio Medical, Inc. is a medical-device company focused on developing catheter-based technologies for the treatment of cardiac arrhythmias, including atrial fibrillation. The company’s work is centered on cardiac ablation, a procedure that uses energy to create targeted lesions in heart tissue responsible for abnormal electrical signals. Its lead technology is the iCLAS system, an integrated cardiac liquid ablation platform designed to support cardiac ablation procedures using ultra-low-temperature cryoablation and pulsed-field ablation capabilities. The system is intended to help physicians treat arrhythmias through catheter-based procedures, with potential applications that include persistent atrial fibrillation and other complex rhythm disorders. Product availability and regulatory authorization may vary by geography and indication. Adagio Medical was founded in 2011 and is based in Laguna Hills, California. The company has focused primarily on research, clinical development and regulatory advancement of its ablation platform, serving the global electrophysiology and cardiovascular-care markets. Its leadership has included founder and Chief Executive Officer Olav Bergheim.AI Generated. May Contain Errors. Read More Adagio Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreADGM MarketRank™: Adagio Medical scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingHold Consensus RatingAdagio Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialAdagio Medical has a consensus price target of $3.50, representing about 2,436.2% upside from its current price of $0.14.Amount of Analyst CoverageAdagio Medical has only been the subject of 1 research reports in the past 90 days.Read more about Adagio Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Adagio Medical are expected to decrease in the coming year, from ($1.25) to ($1.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Adagio Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Adagio Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAdagio Medical has a P/B Ratio of 0.23. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Adagio Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.02% of the float of Adagio Medical has been sold short.Short Interest Ratio / Days to CoverAdagio Medical has a short interest ratio ("days to cover") of 2.26, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Adagio Medical has recently increased by 59.27%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdagio Medical does not currently pay a dividend.Dividend GrowthAdagio Medical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Adagio Medical this week, compared to 2 articles on an average week.Search Interest2 people have searched for ADGM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Adagio Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Adagio Medical insiders have not sold or bought any company stock.Percentage Held by Insiders7.81% of the stock of Adagio Medical is held by insiders.Percentage Held by Institutions48.08% of the stock of Adagio Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Adagio Medical's insider trading history. Receive ADGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adagio Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADGM Stock News HeadlinesAdagio Medical Converts Notes to Equity Amid ReviewOctober 1, 2026 | tipranks.comAdagio Medical Initiates Strategic Review and Workforce Reduction While Advancing vCLAS PMASeptember 23, 2026 | finance.yahoo.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.October 6 at 1:00 AM | Reagan Gold Group (Ad)Adagio Medical Announces Strategic Review Process to Maximize Shareholder ValueSeptember 23, 2026 | finance.yahoo.comAdagio Medical Explores Strategic Alternatives, Cuts WorkforceSeptember 23, 2026 | tipranks.comAdagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical ...September 16, 2026 | finance.yahoo.comAdagio Medical Holdings (ADGM) Stock Forecast & Price TargetAugust 26, 2026 | investing.comAdagio Medical Reports Second Quarter 2026 ResultsAugust 11, 2026 | finance.yahoo.comSee More Headlines ADGM Stock Analysis - Frequently Asked Questions How have ADGM shares performed this year? Adagio Medical's stock was trading at $1.04 on January 1st, 2026. Since then, ADGM stock has decreased by 86.7% and is now trading at $0.1380. How were Adagio Medical's earnings last quarter? Adagio Medical Holdings, Inc. (NASDAQ:ADGM) posted its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by $0.03. How do I buy shares of Adagio Medical? Shares of ADGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Adagio Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adagio Medical investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU). Company Calendar Last Earnings8/11/2026Today10/06/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 12 days, ADGM's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ADGM Previous SymbolNASDAQ:ADGM CIK2006986 Webadagiomedical.com Phone(949) 348-1188FaxN/AEmployees41Year Founded2023Price Target and Rating Average Price Target for Adagio Medical$3.50 High Price Target$4.00 Low Price Target$3.00 Potential Upside/Downside+2,436.2%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($1.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$25.08 million Net MarginsN/A Pretax MarginN/A Return on Equity-661.85% Return on Assets-73.35% Debt Debt-to-Equity Ratio4.00 Current Ratio1.41 Quick Ratio1.15 Sales & Book Value Annual Sales$600 thousand Price / Sales5.11 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book0.23Miscellaneous Outstanding Shares22,210,000Free Float20,475,000Market Cap$3.06 million OptionableN/A Beta0.01 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:ADGM) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredParisian Penthouse: $650 a month (and your own chauffeur)A penthouse apartment for 650 a month in one of the ritziest neighborhoods in the city, comparable to Manhatta...International Living | SponsoredTrump Once Threatened THIS Country (Not Iran)Trump recently threatened a major economy not Iran, Canada, Mexico, or China over a new law that could hurt on...Monument Traders Alliance | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagio Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagio Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.